Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Assistance Publique - Hôpitaux de Paris |
---|---|
Information provided by: | Assistance Publique - Hôpitaux de Paris |
ClinicalTrials.gov Identifier: | NCT00307658 |
The aim of this study is to study the efficacy of intravenous immunoglobulins for inducing remission in patients relapsing of systemic vasculitides.
Condition | Intervention | Phase |
---|---|---|
ANCA + Vasculitides Relapsing Either Under Corticosteroid and Immunosuppressant Therapies or After One Year Post Treatment. |
Drug: Intravenous immunoglobulins (human immunoglobulins G) |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Intravenous Immunoglobulin After Relapse in Vasculitis (Microscopic Polyangiitis, Wegener’s Granulomatosis and SHURG-STRAUSS Syndrome) During and After Corticosteroids and Immunosuppressant Therapies a Multicenter Prospective Trial |
Estimated Enrollment: | 40 |
Study Start Date: | March 2001 |
Estimated Study Completion Date: | July 2006 |
The aim of this study will assess the effects of intravenous immunoglobulin in ANCA+ vasculitides (Microscopic Polyangiitis, Wegener’s granulomatosis and Churg-Strauss syndrome) who relapse under corticosteroid and immunosuppressant therapies or after one year post treatment.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
France | |
Hôpital COCHIN | |
PARIS, France, 75679 | |
Hopital Cochin | |
PARIS, France, 75679 |
Principal Investigator: | Loïc GUILLEVIN, MD,PhD | Assistance Publique - Hôpitaux de Paris |
Study ID Numbers: | P991006 |
Study First Received: | March 27, 2006 |
Last Updated: | May 18, 2006 |
ClinicalTrials.gov Identifier: | NCT00307658 History of Changes |
Health Authority: | France: Ministry of Health |
ANCA associated Vasculitides Relapse intravenous Immunoglobulins Corticosteroid Immunosuppressant |
Vasculitis Immunologic Factors Vascular Diseases Immunosuppressive Agents Recurrence Microscopic Polyangiitis Antibodies |
Wegener Granulomatosis Immunoglobulins, Intravenous Immunoglobulin G Rho(D) Immune Globulin Wegener's Granulomatosis Immunoglobulins |
Disease Attributes Vasculitis Immunologic Factors Physiological Effects of Drugs Vascular Diseases Immunosuppressive Agents Pharmacologic Actions Recurrence |
Antibodies Pathologic Processes Immunoglobulins, Intravenous Immunoglobulin G Rho(D) Immune Globulin Cardiovascular Diseases Immunoglobulins |